Preclinical evidence further supports these findings: in insulin-resistant rat models, DPP-4is such as sitagliptin and vildagliptin improve cognitive behaviors and restore cerebral mitochondrial function, demonstrating protective effects against diet-induced cognitive decline (74). This evidence concerns the gene INS and Mental deterioration.